Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the sales threshold triggering the second USD 2.5 million milestone payment this year.
David Veitch, Basilea's Chief Executive Officer, stated: 'This milestone payment for the Asia Pacific region, including China, reflects the strong and growing global demand for novel antifungal therapies. Continued growth of Cresemba, particularly in China, where uptake has been especially robust, reinforces its significant clinical value for patients facing life-threatening infections. We congratulate our partner Pfizer for their ongoing commitment to making Cresemba available to patients in need.'
The license agreement between Basilea and Pfizer for Cresemba covers Europe (excluding the Nordic countries) as well as China and 16 countries in the Asia Pacific region.
Cresemba is marketed in more than 70 countries. According to the latest available market data, total global in-market sales of Cresemba in the twelve-month period between January and December 2024 amounted to USD 562 million, a 19 percent growth year-on-year, making it the largest branded antifungal for invasive fungal infections worldwide.1
About Cresemba® (isavuconazole)
Cresemba, with the active ingredient isavuconazole, is an intravenous (i.v.) and oral azole antifungal. Basilea has entered into several license and distribution agreements for Cresemba covering approximately 115 countries. In China, the oral and intravenous formulations are approved for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis. Isavuconazole is also approved in the European Union2, the United Kingdom3, the United States (US)4 and several additional countries including in the Asia Pacific region.5
About Basilea
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial or fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN). Please visit basilea.com.
Disclaimer
This communication expressly or implicitly contains certain forward-looking statements, such as "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions concerning Basilea Pharmaceutica Ltd, Allschwil and its business, including with respect to the progress, timing and completion of research, development and clinical studies for product candidates. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Basilea Pharmaceutica Ltd, Allschwil to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Basilea Pharmaceutica Ltd, Allschwil is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
For further information, please contact:
Peer Nils Schröder, PhDHead of Corporate Communications & Investor RelationsBasilea Pharmaceutica International Ltd, Allschwil Hegenheimermattweg 167b4123 AllschwilSwitzerland
Phone
+41 61 606 1102
media_relations@basilea.cominvestor_relations@basilea.com
This press release can be downloaded from www.basilea.com.
References
IQVIA Analytics Link, December 2024. In-market sales reported as moving annual total (MAT) in US dollar.
European Public Assessment Report (EPAR) Cresemba: https://www.ema.europa.eu/en/medicines/human/EPAR/cresemba [Accessed: June 04, 2025]
Summary of Product Characteristics (SmPC) Cresemba: https://www.medicines.org.uk/emc/search?q=cresemba [Accessed: June 04, 2025]
Full US prescribing information: https://www.astellas.us/docs/cresemba.pdf [Accessed: June 04, 2025]
The registration status and approved indications may vary from country to country.
Attachment
Press release (PDF)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Key Points Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P 500 index fund. Still, Pfizer today offers a fat dividend and plenty of growth potential. 10 stocks we like better than Pfizer › Wondering how well you'd have done if you'd invested in pharmaceutical giant Pfizer (NYSE: PFE) three years ago and hung on? Well, I'm afraid the answer isn't pretty: If you'd investing $1,000 in Pfizer on Aug. 8, 2022, hung on and reinvested dividends, that sum would have been worth $585 on Aug. 8, 2025. Ouch! For some context, during those same three years, the S&P 500 index of 500 of America's biggest companies averaged gains of roughly 17% per year, turning $1,000 into $1,615. Here's some good news, though: Stock investors need to look forward much more than backward. Trailing returns are in the past. What matters most for current Pfizer investors and would-be Pfizer investors is how the company will perform from here on. And Pfizer's future is looking promising. Some investors have been disappointed in Pfizer when they've compared recent results to those from the past. But those past years were exceptional boom years thanks to Pfizer's COVID-19 vaccine and Paxlovid COVID-19 treatment. Those were in great demand, but demand has fallen. Others worry because some of Pfizer's big sellers, such as Eliquis, Ibrance, Inlyta, Xeljanz, Xtandi, and Vyndaqel, are coming off patent protection in the next few years. Pfizer has been planning for that, and investing in its pipeline, which features more than 100 active programs -- many of which are in oncology. Pfizer has also been getting additional approvals for its drugs, and it has been cutting its costs in an effort to boost profitability. Finally, Pfizer is a dividend-paying stock, with a whopping recent dividend yield of 7%. So as you invest in Pfizer and wait for its investments to pay off, you'll be rewarded. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 11, 2025 Selena Maranjian has positions in Pfizer. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy. If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool
Business Upturn
34 minutes ago
- Business Upturn
Marine Sensors Market to Reach $1.9 Billion by 2028, Growing at 6.5% CAGR: Exploring the Depths of Growth
By GlobeNewswire Published on August 12, 2025, 05:00 IST Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) — The Marine Sensors Market size was estimated at USD 1.3 billion in 2022 and is predicted to increase from USD 1.4 Billion in 2023 to approximately USD 1.9 Billion by 2028, expanding at a CAGR of 6.5% from 2023 to 2028. The Marine Sensors Industry is driven by factors such as increasing demand for UUV's and AUV', along with the increasing demand of the maritime transportation, navies are focusing on technologically advanced marine vessels. Download PDF Brochure: Major Key Players in the Marine Sensors Industry: Honeywell International Inc. (US), Eaton Corporation (Ireland), TE Connectivity (Switzerland), Garmin Ltd. (US), and Curtiss Wright (US) Marine Sensors Market Key Dynamics: Driver: Growing Demand for ROV and AUV Propels the Demand for Marine Sensors ROVs and AUVs are used in offshore oil and gas operations for a variety of tasks, such as inspecting pipelines and platforms, performing maintenance and repair tasks, and conducting seabed surveys. ROVs and AUVs are used in oceanographic research to collect data on a variety of oceanographic conditions, such as temperature, salinity, currents, and waves. This data can be used to study the ocean and its inhabitants, and to develop new oceanographic models. These ROV's and AUV's are equipped with various types of sensors such as sonar and other sensors to help operators navigate and perform tasks underwater. Opportunity: Integration of Artificial Intelligence (AI), Internet of Things (IoT) With Advanced Marine Sensors Technology The integration of AI and IoT is a significant opportunity for the marine sensors market. AI can be used to analyze the data collected by marine sensors to identify patterns and trends that would be difficult or impossible to detect manually. This information can then be used to improve marine safety, efficiency, and environmental protection. AI can be used to analyze data from marine sensors to predict when maintenance is needed. This can help to reduce downtime and costs. AI can be used to monitor data from marine sensors in real time to identify potential problems. Challenges: Maintenance Process and Calibration of Sensors The maintenance process and calibration of marine sensors is a challenge for the marine sensors market for a number of reasons such as situations where marine sensors are exposed to a harsh and corrosive marine environment, which can damage sensors and make them inaccurate many marine sensors are located in remote and inaccessible locations, which make it difficult and expensive to perform maintenance and calibration, downtime caused by sensor failures can be very costly for marine operations. Marine sensors are becoming increasingly complex, which makes it difficult and time-consuming to perform maintenance and calibration. Ask for Sample Report: Marine Sensors Market Growth in the APAC Region: Asia Pacific is Expected to Account for the Highest CAGR in the Forecasted Period Asia Pacific is estimated to account for the highest CAGR in the forecasted period. The market growth in this region is expected to be fueled by an advancement in technology and investments in sensors during the forecast period. The major countries considered under this region are the China, India, South Korea, Japan, Australia and Rest of Asia Pacific. The Asia Pacific region is leading the way in the adoption of autonomous ships and UUVs. These vessels rely heavily on marine sensors to operate safely and effectively. The Asia Pacific region is experiencing rapid economic development. This is leading to increased investment in maritime infrastructure and operations, which is driving demand for marine sensors. Governments in the Asia Pacific region is supportive of the marine sensors industry. Recent Developments In July 2023 , Curtiss-Wright secured contracts exceeding USD 250 million. These contracts pertain to the supply of propulsion valves, pumps, and advanced instrumentation and control systems for the esteemed U.S. Navy programs, specifically the Virginia-class nuclear-powered attack submarines, Columbia-class submarines, and Ford-class aircraft carriers. , Curtiss-Wright secured contracts exceeding USD 250 million. These contracts pertain to the supply of propulsion valves, pumps, and advanced instrumentation and control systems for the esteemed U.S. Navy programs, specifically the Virginia-class nuclear-powered attack submarines, Columbia-class submarines, and Ford-class aircraft carriers. In March 2022 , The U.S. Navy awarded Raytheon, USD 651 million contract to equip all newly commissioned surface ships, ranging from small patrol vessels to massive aircraft carriers, with advanced radar systems capable of detecting and monitoring both hostile missiles and aircraft simultaneously. , The U.S. Navy awarded Raytheon, USD 651 million contract to equip all newly commissioned surface ships, ranging from small patrol vessels to massive aircraft carriers, with advanced radar systems capable of detecting and monitoring both hostile missiles and aircraft simultaneously. In November 2021 , Eaton entered into aa agreement with the U.S. Department of Defense (DoD) to produce inductive proximity sensors specifically designed for essential operations in challenging naval conditions. , Eaton entered into aa agreement with the U.S. Department of Defense (DoD) to produce inductive proximity sensors specifically designed for essential operations in challenging naval conditions. In October 2022, Teledyne FLIR Defense secured a USD 48.7 Million contract to supply Maritime Forward Looking Infrared (MARFLIR) II sensors and various versions of its SeaFLIR® 280-HD surveillance systems to the United States Coast Guard (USCG) under a firm-fixed-price, indefinite-delivery/indefinite-quantity agreement. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
34 minutes ago
- Business Upturn
Steel Rebar Market worth $268.4 billion by 2030, at a CAGR of 4.0%, says MarketsandMarkets™
Delray Beach, FL, Aug. 11, 2025 (GLOBE NEWSWIRE) — The Steel Rebar Market was USD 212.9 billion in 2024, and it is projected to reach USD 268.4 billion in 2030, at a CAGR of 4.0%, registering a CAGR of 6.7% during the forecast period, as per the recent study by MarketsandMarkets™. Steel rebar, or reinforcing bar, is a steel rod used to strengthen concrete and masonry structures. It offers tensile strength, which concrete lacks, helping to prevent cracking and structural failure under tension. Rebar is usually made of carbon steel and comes in different grades, sizes, and surface finishes to enhance bonding with concrete. It is used in most building projects, bridges, and infrastructure to boost the durability, stability, and load-carrying capacity of reinforced concrete structures. Download PDF Brochure: Browse in-depth TOC on 'Steel Rebar Market' 309 – Market Data Tables 61 – Figures 290 – Pages List of Key Players in Steel Rebar Market: Nippon Steel Corporation (Japan) ArcelorMittal (Luxemberg) Gerdau S/A (Brazil) Nucor Corporation (US) Commercial Metals Company (US) TATA Steel (India) Steel Authority of India Limited (India) Mechel PAO (Russia) Steel Dynamics, Inc. (US) NLMK Group (Russia) JSW (India) Baosteel Group Co., Ltd. (China) Drivers, Opportunities and Challenges in Steel Rebar Market: Drivers: Expansion of urban mass transit systems across developing economies Restraint: Import tariffs and anti-dumping measures Opportunity: Green steel rebar from hydrogen-based DRI Challenge: Lack of recycling infrastructure in emerging economies Get Sample Pages: Key Findings of the Study: By end-use sector, the infrastructure segment accounted for the largest market share in 2024. By coating type, the plain carbon steel segment is projected to witness the highest CAGR during the forecast period. Asia Pacific accounted for the largest share of the market in 2024. The steel rebar market is divided by type, which includes deformed and mild. Deformed steel bars feature ribs, lugs, and horns on their surface to enhance the bond between concrete and the rebar, reducing the risk of concrete corrosion. They are widely used across various sectors, such as the construction industry, for building bridges and skyscrapers. Their superior tensile strength and durability have gained recognition worldwide for infrastructure and commercial construction. By contrast, mild steel rebar, which is smooth and has much lower tensile strength, is used for smaller projects like garden walls or reinforcing other types of temporary large structures. Although soft rebar is cheaper, its weak adhesion and tendency to slip have led to decreased use in recent years for new building materials. The steel rebar market is segmented by process into basic oxygen steelmaking (BOS) and electric arc furnace (EAF). The BOS process is the most commonly used method for steel production, primarily in regions with high steel demand and abundant virgin iron ore supplies. It is widely used by integrated steel plants for large-scale manufacturing. Meanwhile, the EAF route is quickly gaining popularity as a flexible, low-carbon option that recycles scrap steel. EAF is especially favored in sustainable steelmaking and circular economy applications. With strict environmental regulations and a plentiful supply of scrap, EAF is expected to grow faster in the steel rebar market. The steel rebar market is segmented by coating type into plain carbon steel rebar, galvanized steel rebar, and epoxy-coated steel rebar. Plain carbon steel rebar (ASTM A1044, available in ASTM A615, A706, A775, and A996) is made from unfinished-rolled steel and is the most common type of rebar. However, it lacks corrosion resistance, making it unsuitable for moist conditions. Galvanized steel rebar, which is zinc-coated, offers rust and corrosion resistance suitable for coastal or humid environments. Epoxy-coated steel reinforcement (ASTM A775) provides an effective solution for preventing corrosion of steel rebar and prolonging the lifespan of building structures. Increasing focus on infrastructure longevity and reducing maintenance costs is driving demand for coated rebar, especially zinc and epoxy-coated types. Get Customization on this Report: The steel rebar market is also segmented by bar size, which includes #3, #4, #5, #8, and other sizes. #3 rebar, being smaller, is used in light-duty construction such as reinforcing patios, driveways, and residential slabs. #4 and #5 rebar sizes are commonly used for these applications, balancing strength with ease of concrete placement in foundations, walls, and columns in both residential and commercial buildings. Conversely, larger #8 rebar is generally used for heavy-duty projects like bridges, large industrial facilities, and multi-story buildings requiring substantial load-bearing capacity. The selection of bar size depends on structural design, service conditions, and building code requirements for different types of structures. The steel rebar market is segmented based on end-use sector, which includes infrastructure, housing & industrial. The infrastructure vertical is a major revenue contributor due to the huge amount of government spending on roads, bridges, railways, and airports in developing countries. Steel rebar is a must in order to maintain the structure and integrity of these heavy concrete projects. Another significant source of contribution is the housing sector, which is driven by urbanization, population increase, and the requirement for affordable as well as tall apartments. The industrial segment sells steel rebar that is included in the construction of manufacturing plants, warehouses, coal and battery plants, and other industrial facilities. The rising industrialization and the development of energy and logistics systems have been demanding more in this segment. Rebar specifications and quantity are also affected by the specific construction requirements of each sector. The steel rebar market is studied in five regions: Asia Pacific, Europe, North America, the Middle East & Africa, and South America. Of these, Asia Pacific is leading the market and is projected to experience the fastest CAGR during the forecast period. This is driven by the rapid pace of urbanization, the development of large-scale infrastructure, and the significant government spending on transportation, energy, and housing in countries such as China, India, Indonesia, and Vietnam. Projects such as India's Smart Cities Mission and China's Belt and Road Initiative are driving steel rebar demand in the region. North America is a market that is relatively mature, with demand through rehabilitation of aging infrastructure and modernization, particularly in the US and Canada. The U.S. Infrastructure Investment and Jobs Act has increased demand for rebar for bridges, highways, and public transit systems. The market is also witnessing a growing preference for epoxy-coated and corrosion-resistant rebars in light of stringent construction and safety standards. Europe also indicates firm demand, driven by residential renovation, energy-efficient building construction, and earthquake-resistant buildings in Southern and Eastern Europe. South America, led by Brazil and Argentina, is slowly growing, fueled by public infrastructure projects and an increased demand for housing. But economic disruptions could out turn consistent development. The Middle East & Africa coupler for hollow structures market is proving to be a promising market. Continuation of mega projects, including construction sites for Saudi Arabia's NEOM city and UAE infrastructure development projects, rollout of Vision Plan 2021, and introduction of tourism and energy sources are expected to aid in the long-term demand for high-strength and durable steel rebar in the region. Browse Adjacent Markets Building and Construction Market Research Reports & Consulting Related Reports: Green Hydrogen Market Protective Packaging Market Building Thermal Insulation Market Silicone Elastomers Market Adhesives & Sealants Market Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
